Biotech & Health
Comparing Advanced CRISPR-Cas9 Delivery Systems: Specificity, Immunogenicity, and Clinical Progress
The effectiveness and safety of CRISPR-Cas9 gene editing therapies depend critically on delivery systems. This article compares viral vectors like AAVs and lentiviruses, non-viral options like LNPs, and ex vivo methods like electroporation, evaluating their specificity, immunogenicity, and clinical progress.
Lena Petrova·October 1, 2026
